News
DIAGNOS and ÉTS launch a Research Chair dedicated to artificial intelligence
Market time --:--:--

500000 +

images analysées

About Our Vision

L’intelligence artificielle au service de la santé visuelle, pour un impact à grande échelle

Chez DIAGNOS, l’intelligence artificielle est un levier pour transformer durablement la santé visuelle. Nos technologies d’analyse rétinienne permettent une détection plus précoce et une interprétation accélérée des maladies oculaires, dans le respect des normes éthiques les plus strictes. Notre ambition est de rendre les outils de dépistage plus accessibles, plus fiables et mieux intégrés aux pratiques cliniques, afin de soutenir des millions de patients à travers le monde.

Why Choose DIAGNOS?

L’intelligence artificielle au service d’une vision préservée, à grande échelle

Chez DIAGNOS, chaque analyse compte. Préserver la vision, c’est préserver l’autonomie, la qualité de vie et la dignité des patients. Nos solutions d’intelligence artificielle permettent de détecter précocement les maladies oculaires, avant l’apparition des premiers signes cliniques. Conçues pour une intégration fluide dans les environnements cliniques et hospitaliers, elles offrent aux professionnels de santé des analyses rapides, précises et sécurisées, sans compromis sur la confidentialité des données.

Un dépistage intelligent, rapide et non invasif, adapté aux pratiques réelles

Un dépistage intelligent, rapide et non invasif, adapté aux pratiques réelles

235 +

Equipped Centers

420 +

Eye Images Analyzed

30 K

Medical Partnerships

305 +

Validated Studies / Awards

Ecosystem

Media center
Couverture médiatique

Media center

DIAGNOS has been featured in a range of specialized media outlets, business publications, and health programs. Below is a selection of recent media coverage
  • Le Devoir — “DIAGNOS and ÉTS announce over $1 million in federal funding to drive innovation in next-generation retinal AI.”
  • Radio-Canada / ICI Gaspésie — Coverage of the deployment of DIAGNOS’ AI-assisted diabetic retinopathy screening across the CISSS de la Gaspésie network
  • La Presse (Innovation Special Report) — DIAGNOS featured as a Quebec leader in the application of AI to medical diagnosis (FLAIRE platform)
Access resources
Clinical research
Publications scientifiques

Strategic partnerships and clinical research

DIAGNOS relies on close collaborations with leading clinical centers and top-tier academic institutions around the world. It is through this constant dialogue between real-world practice and research that we anchor the scientific rigor of our retinal imaging analyses. Our publications document the accuracy and reproducibility of our work, with a clear ambition: to enable earlier detection and more rigorous follow-up, as close as possible to real clinical practice
  • Early detection and emerging signals
  • Multicenter validation in real-world settings
  • Tracking the progression of retinal conditions
  • Analytical precision and reproducibility
Access resources

Investor area

Press releases

DIAGNOS is committed to maintaining an ongoing and transparent dialogue with all of its stakeholders. More than a simple flow of information, our press releases serve as the official record of our strategic deployment and our contribution to global health. Each announcement marks a meaningful step in advancing our mission, reflecting both the strength of our business model and our ability to translate technological innovation into tangible clinical value

  • Strategic Partnerships & Clinical Deployment: Announcements related to partnerships with hospital networks, specialized clinics, and major distribution players on an international scale
  • Geographic Expansion & Licensing: Updates on our progress in new global markets and the securing of operating licenses from health authorities
  • Technological Innovation: Highlights of critical advances in the development of our next-generation algorithms and the outcomes of our clinical validation efforts
  • Institutional Recognition: Showcasing major government support, industry recognition, and our participation in leading-edge research initiatives
Access resources
Stock market and financial information

DIAGNOS is committed to upholding the highest standards of financial transparency and corporate governance. As a public company, we provide markets and shareholders with the tools they need to monitor their investment in a rigorous and compliant manner

  • Listings and stock exchanges: Ongoing information on our activities on the TSX Venture Exchange (ADK) and the OTCQB (DGNOF). We ensure the disclosure of regulatory information in accordance with the requirements of the relevant authorities
  • Tax compliance and forms: Access to the official tax documents required for security holders, including IRS Form 8937 for U.S. investors, ensuring compliance with international tax obligations
Access resources
Resource center

The Resource Center brings together all of DIAGNOS’ institutional and regulatory documentation in one place. It serves as a reference library for investors, analysts, and partners seeking a deeper understanding of the company and its operating framework

  • Press Release Archive
  • Annual Reports, Consolidated Financial Statements
  • Stock market and financial information
Access resources

Management Team

André Larente, Président - Directeur

André Larente

President - Director

Mr. Larente is the architect of DIAGNOS’ strategic vision. A seasoned leader, he brings extensive senior executive experience gained at global technology leaders such as Siemens, Honeywell Information Systems, Cognos, and Tandem Computers
Yves-Stéphane Couture, Chef de l’exploitation

Yves-Stéphane Couture

Chief Operating Officer

Mr. Couture is Chief Operating Officer of DIAGNOS. A seasoned leader, he brings more than 25 years of experience in strategic leadership and technology deployment, gained at global companies such as Nokia and Alcatel-Lucent
Marc-André Massue, Chef des finances

Marc-André Massue

Chief Financial Officer

Mr. Massue is DIAGNOS’ Chief Financial Officer. A Chartered Professional Accountant (CPA) and graduate of HEC Montréal, he brings more than 20 years of financial management experience in high-technology companies
Dr Hadi Chakor, Médecin-chef (CMO)

Dr Hadi Chakor

Chief Medical Officer (CMO)

A recognized expert in retinal disease and visual electrophysiology, Dr. Chakor leads DIAGNOS’ global medical affairs. He is the guarantor of the company’s scientific and clinical rigor
Dr Ismail Ben Ayed, Scientifique en chef, Intelligence Artificielle

Dr Ismail Ben Ayed

Chief Scientist, Artificial Intelligence

Dr. Ben Ayed leads DIAGNOS’ technological innovation. A globally recognized expert in computer vision and deep learning, he holds a Canada Research Chair in medical image analysis and is a professor at ÉTS Montréal
Silvain Bériault, PhD, Directeur du développement logiciel

Silvain Bériault, PhD

Director of Software Development

Mr. Bériault is a high-level expert in software engineering and artificial intelligence applied to the medical field. He holds a PhD in biomedical engineering from McGill University and brings 15 years of strategic experience, including leadership roles at global innovators such as Elekta

Our team

Board of Directors

Philippe Couillard, Président du conseil d’administration et Directeur

Philippe Couillard

Chairman of the Board of Directors and Director

Dr. Couillard is Chairman of the Board of DIAGNOS. A neurosurgeon by training and former Premier of Québec, he brings world-class authority in governance and public health policy to the company.
André Larente, Président - Directeur

André Larente

President - Director

Mr. Larente is the architect of DIAGNOS’ strategic vision. A seasoned leader, he brings extensive senior executive experience gained at global technology leaders such as Siemens, Honeywell Information Systems, Cognos, and Tandem Computers
Michael Braeuel, Directeur

Michael Braeuel

Director

Holding a master’s degree in engineering and an accomplished entrepreneur, Mr. Braeuel is an expert in high-technology systems integration. With more than 30 years of experience, he has successfully founded and led companies specializing in advanced industrial inspection technologies.
Robert Dunn, Directeur

Robert Dunn

Director

Mr. Dunn brings more than 40 years of expertise in insurance and risk management to DIAGNOS. Former Executive Vice President of HUB International Québec, he has deep command of the financial and communications dynamics of large organizations.

Our team

Advisory Council

Ed Weiner, Conseiller

Ed Weiner

Advisor

A respected figure in the optical industry, Ed Weiner is the founder and former president of National Vision Associates, one of the largest optical retailers in the United States. He brings DIAGNOS unique expertise in scaling large distribution network
Dr Tomas J. Philipson, Conseiller

Dr Tomas J. Philipson

Advisor

A world-renowned health economist, Dr. Philipson served as Acting Chairman of the White House Council of Economic Advisers. An expert in U.S. regulatory matters, he has advised the FDA and CMS on healthcare policy and reimbursement mechanisms.
Dr Barry Ginsberg, Conseiller

Dr Barry Ginsberg

Advisor

With more than 30 years of experience in optometry, Dr. Ginsberg is a recognized specialist in age-related macular degeneration and glaucoma. He brings DIAGNOS essential frontline expertise for integrating AI solutions into clinical settings.
Dr Pierre-Luc Charlebois, Conseiller

Dr Pierre-Luc Charlebois

Advisor

An orthopedic surgeon and expert in healthcare management, Dr. Charlebois holds dual training in medicine from the Université de Montréal and health economics from the London School of Economics (LSE). He advises DIAGNOS on care pathway optimization and the systemic integration of technology.

Besoin d'une solution d’IA pour le dépistage oculaire ?

Contactez DIAGNOS — nos équipes vous accompagnent

Contact

Contactez-nous

Contact

Contactez-nous

    +1 (450) 678-8882

    info@diagnos.com

    Accueil DIAGNOS